Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$19.86 - $26.93 $79,440 - $107,720
-4,000 Reduced 21.05%
15,000 $4,000
Q2 2023

Jul 18, 2023

BUY
$16.44 - $21.1 $246,600 - $316,500
15,000 Added 375.0%
19,000 $32,000
Q1 2023

May 01, 2023

BUY
$16.26 - $21.73 $65,040 - $86,920
4,000 New
4,000 $13,000
Q3 2022

Oct 25, 2022

BUY
$20.88 - $28.21 $62,640 - $84,630
3,000 New
3,000 $11,000
Q3 2020

Oct 27, 2020

SELL
$26.0 - $34.5 $28,600 - $37,950
-1,100 Closed
0 $0
Q2 2020

Jul 22, 2020

SELL
$14.11 - $29.42 $134,045 - $279,490
-9,500 Reduced 89.62%
1,100 $0
Q1 2020

May 07, 2020

BUY
$13.63 - $33.98 $144,478 - $360,187
10,600 New
10,600 $113,000
Q1 2019

May 10, 2019

SELL
$13.91 - $31.15 $83,460 - $186,900
-6,000 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$11.6 - $18.7 $23,200 - $37,400
-2,000 Reduced 25.0%
6,000 $42,000
Q3 2018

Nov 07, 2018

BUY
$18.95 - $28.08 $85,275 - $126,359
4,500 Added 128.57%
8,000 $22,000
Q2 2018

Aug 10, 2018

BUY
$20.0 - $29.72 $70,000 - $104,020
3,500 New
3,500 $17,000
Q1 2018

May 11, 2018

SELL
$21.69 - $32.99 $6,507 - $9,897
-300 Closed
0 $0
Q4 2017

Jan 17, 2018

SELL
$26.43 - $31.78 $243,156 - $292,376
-9,200 Reduced 96.84%
300 $0
Q3 2017

Oct 17, 2017

BUY
$11.61 - $31.21 $110,295 - $296,495
9,500
9,500 $2,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.